The concept of coronavirus disease 2019 (COVID-19)-related cytokine storm syndrome
(COVID-CSS) emerged early in the severe acute respiratory syndrome coronavirus 2 (SARS …

Pathogenic human coronavirus infections, such as severe acute respiratory syndrome CoV
(SARS-CoV) and Middle East respiratory syndrome CoV (MERS-CoV), cause high morbidity …

Abstract COVID-19 is associated with 5.1% mortality. Although the virological,
epidemiological, clinical, and management outcome features of COVID-19 patients have …

Background Severe COVID-19 has a high mortality rate. Comprehensive pathological
descriptions of COVID-19 are scarce and limited in scope. We aimed to describe the …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious respiratory disorder caused
by a new coronavirus called SARS-CoV-2. The pathophysiology of severe COVID-19 is …

Purpose Cytokine storm, an uncontrolled overproduction of inflammatory cytokines
contributing to an aberrant systemic inflammatory response, is a major pathological feature …

Context.—The novel coronavirus disease 2019 (COVID-19) pandemic is significantly
changing methodologic approaches in all branches of the health system. From a forensic …

Summary Background In December 2019, viral pneumonia outbreaks caused by the novel
coronavirus occurred in Wuhan, China, and spread rapidly worldwide, the illness progress …

The current outbreak of COVID-19 severe respiratory disease, which started in Wuhan,
China, is an ongoing challenge, and a major threat to public health that requires …

Objective: Alveolar-capillary endothelial cells can be activated by severe acute respiratory
syndrome coronavirus 2 infection leading to cytokine release. This could trigger endothelial …